Cargando…
Pharmacokinetic and molecular docking studies to design antimalarial compounds targeting Actin I
OBJECTIVE: Malaria is an ancient disease that still causes more than 200 million of cases 7 with high mortality globally. Identification of new drug targets and development of novel antimalarial drugs with unique mode of action encounter the drug resistance and reduce the mortality by Plasmodium par...
Autores principales: | Guleria, Vandana, Pal, Tarun, Sharma, Bhanu, Chauhan, Shweta, Jaiswal, Varun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Qassim Uninversity
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589829/ https://www.ncbi.nlm.nih.gov/pubmed/34916893 |
Ejemplares similares
-
Antimalarial properties and molecular docking analysis of compounds from Dioscorea bulbifera L. as new antimalarial agent candidates
por: Chaniad, Prapaporn, et al.
Publicado: (2021) -
Pharmacokinetic Study and Bioavailability of a Novel Synthetic Trioxane Antimalarial Compound 97/63 in Rats
por: Kushwaha, Hari Narayan, et al.
Publicado: (2014) -
Antimalarial potential of compounds isolated from Mammea siamensis T. Anders. flowers: in vitro and molecular docking studies
por: Chaniad, Prapaporn, et al.
Publicado: (2022) -
MutDock: A computational docking approach for fixed-backbone protein scaffold design
por: Chauhan, Varun M., et al.
Publicado: (2022) -
Pharmacokinetic evaluation of Chalcone derivatives with antimalarial activity in New Zealand White Rabbits
por: Sinha, Shweta, et al.
Publicado: (2021)